June 2023
Volume 64, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2023
Diagnostic power of rapid objective perimetry in young people with Type 1 Diabetes
Author Affiliations & Notes
  • Ted Maddess
    Eccles Institute of Neuroscience, Australian National University The John Curtin School of Medical Research, Canberra, Australian Capital Territory, Australia
  • Emile MF Rohan
    Eccles Institute of Neuroscience, Australian National University The John Curtin School of Medical Research, Canberra, Australian Capital Territory, Australia
    Discipline of Orthoptics, School of Allied Health, Human Services and Sport, La Trobe University, Bundoora, Victoria, Australia
  • Bhim Bahadur Rai
    Eccles Institute of Neuroscience, Australian National University The John Curtin School of Medical Research, Canberra, Australian Capital Territory, Australia
  • Corinne F Carle
    Eccles Institute of Neuroscience, Australian National University The John Curtin School of Medical Research, Canberra, Australian Capital Territory, Australia
  • Christopher J Nolan
    Eccles Institute of Neuroscience, Australian National University The John Curtin School of Medical Research, Canberra, Australian Capital Territory, Australia
    Endocrinology, The Canberra Hospital, Canberra, Australian Capital Territory, Australia
  • Faran Sabeti
    Eccles Institute of Neuroscience, Australian National University The John Curtin School of Medical Research, Canberra, Australian Capital Territory, Australia
    Optometry, University of Canberra Faculty of Health, Canberra, Australian Capital Territory, Australia
  • Rohan W Essex
    Ophthalmology, The Canberra Hospital, Canberra, New South Wales, Australia
  • Josh van Kleef
    Eccles Institute of Neuroscience, Australian National University The John Curtin School of Medical Research, Canberra, Australian Capital Territory, Australia
  • Footnotes
    Commercial Relationships   Ted Maddess Konan Medical USA, Code F (Financial Support), Konan Medical USA, Code I (Personal Financial Interest), Konan Medical USA, Code P (Patent), Konan Medical USA, Code R (Recipient), EyeCo Pty Ltd, Code S (non-remunerative); Emile Rohan None; Bhim Rai None; Corinne Carle Konan Medical USA, Code P (Patent); Christopher Nolan None; Faran Sabeti None; Rohan Essex None; Josh van Kleef Konan Medical USA, Code P (Patent)
  • Footnotes
    Support  MRFF/MTPConnect BTBR100196
Investigative Ophthalmology & Visual Science June 2023, Vol.64, 2666. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Ted Maddess, Emile MF Rohan, Bhim Bahadur Rai, Corinne F Carle, Christopher J Nolan, Faran Sabeti, Rohan W Essex, Josh van Kleef; Diagnostic power of rapid objective perimetry in young people with Type 1 Diabetes. Invest. Ophthalmol. Vis. Sci. 2023;64(8):2666.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : To examine the diagnostic power of 4th and 5th generation (4G and 5G) objective perimetry stimuli in young people with Type 1 Diabetes (T1D) but no retinopathy.

Methods : We examined 52 young persons with T1D (15.2 ± 3.77 y, 26 females), and 29 normal subjects (16.2 ± 3.65 y, 13 females) with two 5G stimulus methods of the ObjectiveFIELD Analyser (OFA): M18 and W20, which test both eyes in 82 seconds. M18 and W20 test 18 and 20 regions/field spanning the central 20 and 60 deg. These were compared with a 4G stimulus, P131 testing 44 regions of the central 30 deg in 7 minutes. We examined diagnostic power of Total deviations (TDs) and pattern deviations (PDs) based upon Sensitivities, Delays, and linear combination scores. We then assessed diagnostic power as area under receiver operator characteristic plots (AUROC). ROC analysis was repeated for subjects <16 y (25 T1D, 12 control), subjects ≥16 y, and all subjects. For P131 there were 12 controls and 20 T1Ds (ages: 19.2 ± 0.83 and 18.8 ± 2.07 y). Retinal photos showed no classical retinopathy.

Results : For M18 and W20 the worst 3 to 9 regions out of 18 or 20 performed best, indicating focal changes. The combined sensitivity and delay scores performed best. For all subjects the AUROCs for M18 and W20 were 87.5 ± 4.78 and 86.2 ± 5.25% (mean ± SE) for the worst 3 TDs/field. PDs of the younger group gave: 89.7 ± 4.70 and 88.7 ± 5.20%. For sensitivities alone AUROCs were in the mid-70% range (Figure) but combining sensitivity TDs from the spatially independent M18 and W20 tests gave 86.8 ± 5.06%. AUROC for the worst 9 PDs of the P131 combined scores was 77.9 ± 8.50%.

Conclusions : Given that the young people with T1D had no classical retinopathy the diagnostic power of the functional tests was good. The rapid M18 and W20 seemed to outperform P131. The focal damage indicated the effects were not iris neuropathy, which would mimic global OFA changes. The M18 stimuli match the size and shape of the ETDRS retinal thickness grid found on OCT reports allowing easy comparison of structure and function as has been shown in macular degeneration [doi:10.1016/j.xops.2022.100143]. The short 82-second tests are ideal for young people.

This abstract was presented at the 2023 ARVO Annual Meeting, held in New Orleans, LA, April 23-27, 2023.

 

Bars 1 to 4: M18 and W20 %AUROCs for combined per-region sensitivities and delays; ‘All’ means all T1D, ‘<16’ younger T1D. Bar 5: M18 sensitivities alone. Bar 6: combined M18 and W20 sensitivities.

Bars 1 to 4: M18 and W20 %AUROCs for combined per-region sensitivities and delays; ‘All’ means all T1D, ‘<16’ younger T1D. Bar 5: M18 sensitivities alone. Bar 6: combined M18 and W20 sensitivities.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×